These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11384634)

  • 1. Recombinant or urinary follicle-stimulating hormone? A cost-effectiveness analysis derived by particularizing the number needed to treat from a published meta-analysis.
    Ola B; Papaioannou S; Afnan MA; Hammadieh N; Gimba S
    Fertil Steril; 2001 Jun; 75(6):1106-10. PubMed ID: 11384634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cost-effectiveness of IVF in the UK: a comparison of three gonadotrophin treatments.
    Sykes D; Out HJ; Palmer SJ; van Loon J
    Hum Reprod; 2001 Dec; 16(12):2557-62. PubMed ID: 11726574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WITHDRAWN: Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction cycles.
    Daya S; Gunby J
    Cochrane Database Syst Rev; 2007 Jul; 2006(3):CD002810. PubMed ID: 17636708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction cycles.
    Daya S; Gunby J
    Cochrane Database Syst Rev; 2000; (4):CD002810. PubMed ID: 11034767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reflections on the cost-effectiveness of recombinant FSH in assisted reproduction. The clinician's perspective.
    Balasch J; Barri PN
    J Assist Reprod Genet; 2001 Feb; 18(2):45-55. PubMed ID: 11285980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness modelling of recombinant FSH versus urinary FSH in assisted reproduction techniques in the UK.
    Daya S; Ledger W; Auray JP; Duru G; Silverberg K; Wikland M; Bouzayen R; Howles CM; Beresniak A
    Hum Reprod; 2001 Dec; 16(12):2563-9. PubMed ID: 11726575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of highly purified human menopausal gonadotropin vs. recombinant follicle-stimulating hormone in first-cycle in vitro fertilization-intracytoplasmic sperm injection patients.
    Hompes PG; Broekmans FJ; Hoozemans DA; Schats R;
    Fertil Steril; 2008 Jun; 89(6):1685-93. PubMed ID: 17681325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical experience with recombinant follicle-stimulating hormone (FSH) and urinary FSH: a retrospective case- controlled analysis.
    Ravhon A; Lavery S; Aurell R; Trew G; Margara R; Winston R
    Fertil Steril; 2001 May; 75(5):920-5. PubMed ID: 11334903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the cost effectiveness of recombinant versus urinary follicle-stimulating hormone in in vitro fertilization/intracytoplasmic sperm injection programs in the United States.
    Silverberg K; Daya S; Auray JP; Duru G; Ledger W; Wikland M; Bouzayen R; O'Brien M; Falk B; Beresniak A
    Fertil Steril; 2002 Jan; 77(1):107-13. PubMed ID: 11779599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-saving treatment strategies in in vitro fertilization: a combined economic evaluation of two large randomized clinical trials comparing highly purified human menopausal gonadotropin and recombinant follicle-stimulating hormone alpha.
    Wechowski J; Connolly M; Schneider D; McEwan P; Kennedy R
    Fertil Steril; 2009 Apr; 91(4):1067-76. PubMed ID: 18339384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Updated meta-analysis of recombinant follicle-stimulating hormone (FSH) versus urinary FSH for ovarian stimulation in assisted reproduction.
    Daya S
    Fertil Steril; 2002 Apr; 77(4):711-4. PubMed ID: 11937121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction.
    Daya S; Gunby J
    Hum Reprod; 1999 Sep; 14(9):2207-15. PubMed ID: 10469682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costs and outcomes associated with IVF using recombinant FSH.
    Ledger W; Wiebinga C; Anderson P; Irwin D; Holman A; Lloyd A
    Reprod Biomed Online; 2009 Sep; 19(3):337-42. PubMed ID: 19778478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Models of cost-effectiveness of recombinant FSH versus urinary FSH.
    Al-Inany H; Afnan M
    Hum Reprod; 2002 Jun; 17(6):1671-3; author reply 1673-4. PubMed ID: 12042297
    [No Abstract]   [Full Text] [Related]  

  • 16. Cost-Effectiveness Analysis of the Gonadotropin Treatments HP-hMG and rFSH for Assisted Reproductive Technology in France: A Markov Model Analysis.
    Barriere P; Porcu-Buisson G; Hamamah S
    Appl Health Econ Health Policy; 2018 Feb; 16(1):65-77. PubMed ID: 29124676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of recombinant human follicle-stimulating hormone in improving oocyte quality in assisted reproductive techniques.
    Cheon KW; Byun HK; Yang KM; Song IO; Choi KH; Yoo KJ
    J Reprod Med; 2004 Sep; 49(9):733-8. PubMed ID: 15493565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of recombinant FSH and urinary-derived gonadotrophins for IVF or ICSI.
    van Wely M; van der Veen F
    Hum Reprod; 2003 Jul; 18(7):1554-5; author reply 1555-6. PubMed ID: 12832388
    [No Abstract]   [Full Text] [Related]  

  • 19. Meta-analysis of recombinant versus urinary-derived FSH: an update.
    Al-Inany H; Aboulghar M; Mansour R; Serour G
    Hum Reprod; 2003 Feb; 18(2):305-13. PubMed ID: 12571166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cost-effectiveness analysis of freeze-only or fresh embryo transfer in IVF of non-PCOS women.
    Le KD; Vuong LN; Ho TM; Dang VQ; Pham TD; Pham CT; Norman RJ; Mol BWJ
    Hum Reprod; 2018 Oct; 33(10):1907-1914. PubMed ID: 30239784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.